USE OF EPA AND DHA IN SECONDARY PREVENTION OF BRAIN SPILLS.

摘要

The use of a mixture of EPA and DHA, or a pharmaceutically acceptable salt or derivative thereof, for the preparation of an oral medication for the prevention of a stroke in a patient with a symptom of transient ischemic attack and / or amaurosis fugax , wherein the dosage will range from 0.5 to 5.0 g of EPA and DHA per day, and where the ratio of EPA to DHA in said mixture is 1: 2 to 2: 1.